{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T03:39:03Z","timestamp":1785901143728,"version":"3.56.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006823","name":"BOSTON CHILDREN'S HOSPITAL","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006823","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpedsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric Surgery"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jpedsurg.2021.02.036","type":"journal-article","created":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T22:53:52Z","timestamp":1614120832000},"page":"1226-1232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Enhancement of transamniotic stem cell therapy for spina bifida by genetic engineering of donor mesenchymal stem cells with an Fgf2 transgene"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1826-842X","authenticated-orcid":false,"given":"Stefanie P","family":"Lazow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9078-3162","authenticated-orcid":false,"given":"Daniel F","family":"Labuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Kycia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Zurakowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario O","family":"Fauza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpedsurg.2021.02.036_bib0001","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/5584_2019_416","article-title":"Transamniotic stem cell therapy","volume":"1237","author":"Lazow","year":"2020","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"10.1016\/j.jpedsurg.2021.02.036_bib0002","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jpedsurg.2014.10.004","article-title":"Partial or complete coverage of experimental spina bifida by simple intra-amniotic injection of concentrated amniotic mesenchymal stem cells","volume":"50","author":"Dionigi","year":"2015","journal-title":"J Pediatr Surg"},{"issue":"6","key":"10.1016\/j.jpedsurg.2021.02.036_bib0003","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jpedsurg.2015.03.034","article-title":"Trans-amniotic stem cell therapy (TRASCET) minimizes Chiari-II malformation in experimental spina bifida","volume":"50","author":"Dionigi","year":"2015","journal-title":"J Pediatr Surg"},{"issue":"6","key":"10.1016\/j.jpedsurg.2021.02.036_bib0004","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jpedsurg.2016.02.071","article-title":"A comparison between placental and amniotic mesenchymal stem cells for transamniotic stem cell therapy (TRASCET) in experimental spina bifida","volume":"51","author":"Feng","year":"2016","journal-title":"J Pediatr Surg"},{"issue":"2","key":"10.1016\/j.jpedsurg.2021.02.036_bib0005","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jpedsurg.2018.10.086","article-title":"Transamniotic stem cell therapy (TRASCET) in a rabbit model of spina bifida","volume":"54","author":"Shieh","year":"2019","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.jpedsurg.2021.02.036_bib0006","first-page":"1","article-title":"Initial mechanistic screening of transamniotic stem cell therapy in the rodent model of spina bifida: host bone marrow and paracrine activity","volume":"42","author":"Lazow","year":"2020","journal-title":"Fetal Diagn Ther"},{"issue":"11","key":"10.1016\/j.jpedsurg.2021.02.036_bib0007","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1053\/jpsu.2001.27945","article-title":"The amniotic fluid as a source of cells for fetal tissue engineering","volume":"36","author":"Kaviani","year":"2001","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.jpedsurg.2021.02.036_bib0008","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-1-60761-999-4_7","article-title":"Amniotic and placental mesenchymal stem cell isolation and culture","volume":"698","author":"Klein","year":"2011","journal-title":"Methods Mol Biol"},{"issue":"12","key":"10.1016\/j.jpedsurg.2021.02.036_bib0009","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/CIRCULATIONAHA.108.816058","article-title":"Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy","volume":"120","author":"Johnston","year":"2009","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.jpedsurg.2021.02.036_bib0010","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/onc.2015.160","article-title":"Plexin-B1 signalling promotes androgen receptor translocation to the nucleus","volume":"35","author":"Williamson","year":"2016","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.jpedsurg.2021.02.036_bib0011","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.expneurol.2005.03.011","article-title":"Retinoic acid induced myelomeningocele in fetal rats: characterization by histopathological analysis and magnetic resonance imaging","volume":"194","author":"Danzer","year":"2005","journal-title":"Exp Neurol"},{"issue":"1","key":"10.1016\/j.jpedsurg.2021.02.036_bib0012","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jpedsurg.2018.10.031","article-title":"Intra-amniotic injection of alginate microparticles loaded with basic fibroblast growth factor results in partial soft tissue coverage of the spinal defect in a rat myelomeningocele model","volume":"54","author":"Farrelly","year":"2019","journal-title":"J Pediatr Surg"},{"issue":"14","key":"10.1016\/j.jpedsurg.2021.02.036_bib0013","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1016\/j.biomaterials.2010.01.129","article-title":"Intra-uterine tissue engineering of full-thickness skin defects in a fetal sheep model","volume":"31","author":"Hosper","year":"2010","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.jpedsurg.2021.02.036_bib0014","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1159\/000491906","article-title":"Role of FGF-2 transfected bone marrow mesenchymal stem cells in engineered bone tissue for repair of avascular necrosis of femoral head in rabbits","volume":"48","author":"Zhang","year":"2018","journal-title":"Cell Physiol Biochem"},{"issue":"10","key":"10.1016\/j.jpedsurg.2021.02.036_bib0015","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1002\/sctm.17-0039","article-title":"Acceleration of fracture healing by overexpression of basic fibroblast growth factor in the mesenchymal stromal cells","volume":"6","author":"Zhang","year":"2017","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jpedsurg.2021.02.036_bib0016","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.3389\/fimmu.2017.01770","article-title":"Mesenchymal stromal\/stem cells: a new era in the cell-based targeted gene therapy of cancer","volume":"8","author":"Marofi","year":"2017","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.jpedsurg.2021.02.036_bib0017","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.3109\/21691401.2015.1029624","article-title":"Mesenchymal stem cell-based gene therapy: a promising therapeutic strategy","volume":"44","author":"Mohammadian","year":"2016","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"1","key":"10.1016\/j.jpedsurg.2021.02.036_bib0018","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/0963689717728937","article-title":"Utero transplantation of placenta-derived mesenchymal stromal cells for potential fetal treatment of hemophilia A","volume":"27","author":"Kumar","year":"2018","journal-title":"Cell Transplant"},{"issue":"5","key":"10.1016\/j.jpedsurg.2021.02.036_bib0019","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/cbin.10037","article-title":"Engraftment of genetically modified human amniotic fluid-derived progenitor cells to produce coagulation factor IX after in utero transplantation in mice","volume":"37","author":"Yang","year":"2013","journal-title":"Cell Biol Int"},{"issue":"2","key":"10.1016\/j.jpedsurg.2021.02.036_bib0020","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s40291-020-00445-y","article-title":"The future of in utero gene therapy","volume":"24","author":"Peranteau","year":"2020","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.jpedsurg.2021.02.036_bib0021","series-title":"Fetal bone marrow gene delivery via transamniotic stem cell therapy","author":"Lazow","year":"2020"},{"issue":"11","key":"10.1016\/j.jpedsurg.2021.02.036_bib0022","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.3390\/v12101106","article-title":"Gene therapy applications of non-human lentiviral vectors","volume":"12","author":"Munis","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.jpedsurg.2021.02.036_bib0023","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jpedsurg.2020.02.041","article-title":"Postnatal fate of donor mesenchymal stem cells after transamniotic stem cell therapy","volume":"55","author":"Tracy","year":"2020","journal-title":"J Pediatr Surg"}],"container-title":["Journal of Pediatric Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022346821001706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022346821001706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T08:40:03Z","timestamp":1758357603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022346821001706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0022346821001706"],"URL":"https:\/\/doi.org\/10.1016\/j.jpedsurg.2021.02.036","relation":{},"ISSN":["0022-3468"],"issn-type":[{"value":"0022-3468","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancement of transamniotic stem cell therapy for spina bifida by genetic engineering of donor mesenchymal stem cells with an Fgf2 transgene","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpedsurg.2021.02.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}